A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Meeting Abstract
Secord, A. Alvarez, Havrilesky, L. J., Higgins, R. V., Nycum, L. R., Kohler, M. F., Puls, L. E., Holloway, R., Soper, J. T., Valea, F. A., Berchuck, A.